Pulmonary and renal long COVID at two-year revisit.

Publication date: Jul 19, 2024

This study investigated host responses to long COVID by following up with 89 of the original 144 cohorts for 1-year (N = 73) and 2-year visits (N = 57). Pulmonary long COVID, characterized by fibrous stripes, was observed in 8. 7% and 17. 8% of patients at the 1-year and 2-year revisits, respectively, while renal long COVID was present in 15. 2% and 23. 9% of patients, respectively. Pulmonary and renal long COVID at 1-year revisit was predicted using a machine learning model based on clinical and multi-omics data collected during the first month of the disease with an accuracy of 87. 5%. Proteomics revealed that lung fibrous stripes were associated with consistent down-regulation of surfactant-associated protein B in the sera, while renal long COVID could be linked to the inhibition of urinary protein expression. This study provides a longitudinal view of the clinical and molecular landscape of COVID-19 and presents a predictive model for pulmonary and renal long COVID.

Open Access PDF

Concepts Keywords
Covid Clinical finding
Month Machine learning
Proteomics Omics
Renal Respiratory medicine
Surfactant

Semantics

Type Source Name
disease MESH long COVID
disease IDO host
disease MESH COVID-19
drug DRUGBANK Guanosine
drug DRUGBANK Coenzyme M
disease MESH chest pain
disease MESH taste disorders
disease MESH cognitive impairment
disease IDO blood
disease VO time
disease MESH sleep disorders
disease MESH alopecia
disease MESH abnormalities
disease MESH infections
disease MESH influenza
disease VO Viruses
disease MESH joint pain
disease IDO history
disease MESH chronic renal diseases
disease IDO symptom
disease MESH Dysosmia
disease MESH Dysphagia
disease VO organ

Original Article

(Visited 3 times, 1 visits today)